An ITP Patient Taking Eltrombopag Presented with Extreme Thrombocytosis after Orthopedic Surgery
We believe that this rare case was caused by the co-stimulation of eltrombopag, surgery, inflammation, and artificial bone implant. Therefore, ITP patients taking eltrombopag should monitor platelet changes, especially during infection and surgery, so as to adjust the dose of eltrombopag in time.
Authors
- Guoxing Ge
- Xiufang Xu (ORCID: https://orcid.org/0009-0004-8742-9009)
Publication Details
- Journal
- Clinical Laboratory
- Published
- 2025-01-01
- DOI
- https://doi.org/10.7754/clin.lab.2024.241218
- Citations
- 1
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63